Drugs / 13C5-Calcium-L-Leucovorin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00941174 Comparator | Sep 2008 → Mar 2009 | — | The Hospital for Sick Children | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 13C5-Calcium-L-Leucovorin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00941174 ↗ |
| Known as | Calcium Leucovorin | “Using a dual route oral/intravenous, folate (pharmaceutical name Calcium Leucovorin), labeled with a stable isotope will be used to quantitatively measure total folate levels” NCT00941174 ↗ |
| Route | Oral | “Capsule: 400 microg 13C5-Calcium-L-Leucovorin” NCT00941174 ↗ |